# Efficacy and Safety of Fimasartan Alone or Combined With HCTZ in Mexican Patients With Essential Hypertension

> **NCT02466490** · PHASE3 · COMPLETED · sponsor: **Stendhal Americas, S.A.** · enrollment: 272 (actual)

## Conditions studied

- Hypertension, Essential

## Interventions

- **DRUG:** Fimasartan
- **DRUG:** Fimasartan; Hydrochlorothiazide

## Key facts

- **NCT ID:** NCT02466490
- **Lead sponsor:** Stendhal Americas, S.A.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-04
- **Primary completion:** 2014-02
- **Final completion:** 2014-02
- **Target enrollment:** 272 (ACTUAL)
- **Last updated:** 2015-06-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02466490

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02466490, "Efficacy and Safety of Fimasartan Alone or Combined With HCTZ in Mexican Patients With Essential Hypertension". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02466490. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*